デジタルPCR市場：技術別（Droplet Digital Pcr、Chip Based Digital Pcr、Beaming Digital Pcr）、製品タイプ別（デジタルPCRシステム、消耗品・試薬、ソフトウェア、サービス）、用途別（研究、臨床診断、科学捜査、その他）、エンドユーザー別（医薬品・バイオテクノロジー産業、臨床診断研究所、大学、その他組織）：世界の機会分析および産業予測、2020年～2030年

Digital PCR Market By Technology (Droplet Digital Pcr, Chip Based Digital Pcr, Beaming Digital Pcr), By Product Type (Digital Pcr Systems, Consumables And Reagents, Software And Services), By Application (Research, Clinical Diagnostics, Forensic And Others), By End User (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities And Other Organizations), : Global Opportunity Analysis and Industry Forecast, 2020-2030

デジタルPCRの世界市場は、2020年に5億880万ドルで、2021年から2030年にかけてCAGR8.6%を記録し、2030年には13億530万ドルに達すると予測されます。デジタルポリメラーゼ連鎖反応（dPCR）は、サンプル中に存在す... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$6,168 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	210	英語

サマリー

デジタルPCRの世界市場は、2020年に5億880万ドルで、2021年から2030年にかけてCAGR8.6%を記録し、2030年には13億530万ドルに達すると予測されます。デジタルポリメラーゼ連鎖反応（dPCR）は、サンプル中に存在するDNAまたはRNAの量を測定するための感度と再現性の高い方法を提供する核酸の検出と定量のためのアプローチと定義されます。dPCRシステムは、コピー数変動、希少配列検出、突然変異検出、miRNA分析、遺伝子発現分析、次世代シーケンスサンプル定量に有用である。
デジタルポリメラーゼ連鎖反応の世界市場は、感染症の流行や個別化医療に対する認識・受容の高まりにより、近い将来に大きな成長を記録すると予想されています。例えば、世界保健機関（WHO）によると、2020年には全世界で約150万人が結核で死亡しています。Droplet digital PCR（ddPCR）は、結核菌の存在を検出するための分析検査の1つです。また、医療分野における技術の進歩が、予測期間中の市場成長を後押しすると予想されます。
しかし、dPCRデバイスのコスト高と償還の問題が、予測期間中の市場成長を阻害する要因として予想されています。逆に、医療機器分野におけるR&D活動への資金提供の急増は、市場プレイヤーに報酬を得る機会を提供すると予想される。デジタルポリメラーゼ連鎖反応市場は、技術、製品タイプ、アプリケーション、エンドユーザー、地域に区分されます。技術別では、ドロップレットデジタルPCR（ddPCR）、チップベースデジタルPCR、BEAMingデジタルPCRに分類される。
製品タイプ別では、デジタルPCRシステム、消耗品＆試薬、ソフトウェア＆サービスに細分化されます。アプリケーション別では、研究、臨床診断、法医学・その他に分類される。エンドユーザー別では、製薬・バイオテクノロジー業界、臨床診断研究所、大学・その他の組織に区別されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、欧州のその他）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、台湾、アジア太平洋のその他）、LAMEA（ブラジル、サウジアラビア、南アフリカ、LAMEAのその他）で分析されています。
世界のデジタルポリメラーゼ連鎖反応市場で事業を展開する主要企業は、Avance Biosciences、Bio-Rad Laboratories, Inc、Fluidigm Corporation、JN Medsys、Merck KGaA、PreciGenome LLC、Qiagen N.V、Stilla Technologies、Sysmex CorporationおよびThermo Fisher Scientific, Inc.などです。
ステークホルダーにとっての主なメリット
本レポートは、差し迫った投資ポケットを解明するために、現在のトレンドと将来の予測とともに、世界のデジタルPCR市場規模の詳細な分析を提供します。
2021年から2030年までの市場分析を提供しており、利害関係者が市場に存在する機会を活用することを可能にすると期待されます。
地域の包括的な分析は、地域市場を理解し、戦略的な事業計画を促進し、優勢な機会を決定するのに役立ちます。
主要企業のプロファイルと成長戦略を徹底的に分析し、デジタルPCRの世界市場成長の競争展望を理解します。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: DIGITAL PCR MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Droplet Digital Pcr
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Chip Based Digital Pcr
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Beaming Digital Pcr
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: DIGITAL PCR MARKET, BY PRODUCT TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Digital Pcr Systems
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Consumables And Reagents
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Software And Services
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: DIGITAL PCR MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Research
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinical Diagnostics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Forensic And Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: DIGITAL PCR MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Pharmaceuticals And Biotechnology Industries
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Clinical Diagnostic Laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Universities And Other Organizations
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: DIGITAL PCR MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 Asia-Pacific
8.2.1 Key trends and opportunities
8.2.2 Asia-Pacific Market size and forecast, by Technology
8.2.3 Asia-Pacific Market size and forecast, by Product Type
8.2.4 Asia-Pacific Market size and forecast, by Application
8.2.5 Asia-Pacific Market size and forecast, by End User
8.2.6 Asia-Pacific Market size and forecast, by country
8.2.6.1 Japan
8.2.6.1.1 Market size and forecast, by Technology
8.2.6.1.2 Market size and forecast, by Product Type
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 China
8.2.6.2.1 Market size and forecast, by Technology
8.2.6.2.2 Market size and forecast, by Product Type
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Australia
8.2.6.3.1 Market size and forecast, by Technology
8.2.6.3.2 Market size and forecast, by Product Type
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by End User
8.2.6.4 India
8.2.6.4.1 Market size and forecast, by Technology
8.2.6.4.2 Market size and forecast, by Product Type
8.2.6.4.3 Market size and forecast, by Application
8.2.6.4.4 Market size and forecast, by End User
8.2.6.5 South Korea
8.2.6.5.1 Market size and forecast, by Technology
8.2.6.5.2 Market size and forecast, by Product Type
8.2.6.5.3 Market size and forecast, by Application
8.2.6.5.4 Market size and forecast, by End User
8.2.6.6 Taiwan, Republic Of China
8.2.6.6.1 Market size and forecast, by Technology
8.2.6.6.2 Market size and forecast, by Product Type
8.2.6.6.3 Market size and forecast, by Application
8.2.6.6.4 Market size and forecast, by End User
8.2.6.7 Rest of Asia-Pacific
8.2.6.7.1 Market size and forecast, by Technology
8.2.6.7.2 Market size and forecast, by Product Type
8.2.6.7.3 Market size and forecast, by Application
8.2.6.7.4 Market size and forecast, by End User
8.3 LAMEA
8.3.1 Key trends and opportunities
8.3.2 LAMEA Market size and forecast, by Technology
8.3.3 LAMEA Market size and forecast, by Product Type
8.3.4 LAMEA Market size and forecast, by Application
8.3.5 LAMEA Market size and forecast, by End User
8.3.6 LAMEA Market size and forecast, by country
8.3.6.1 Brazil
8.3.6.1.1 Market size and forecast, by Technology
8.3.6.1.2 Market size and forecast, by Product Type
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 Saudi Arabia
8.3.6.2.1 Market size and forecast, by Technology
8.3.6.2.2 Market size and forecast, by Product Type
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 South Africa
8.3.6.3.1 Market size and forecast, by Technology
8.3.6.3.2 Market size and forecast, by Product Type
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Rest of LAMEA
8.3.6.4.1 Market size and forecast, by Technology
8.3.6.4.2 Market size and forecast, by Product Type
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by End User
8.4 North America
8.4.1 Key trends and opportunities
8.4.2 North America Market size and forecast, by Technology
8.4.3 North America Market size and forecast, by Product Type
8.4.4 North America Market size and forecast, by Application
8.4.5 North America Market size and forecast, by End User
8.4.6 North America Market size and forecast, by country
8.4.6.1 U.S.
8.4.6.1.1 Market size and forecast, by Technology
8.4.6.1.2 Market size and forecast, by Product Type
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 Canada
8.4.6.2.1 Market size and forecast, by Technology
8.4.6.2.2 Market size and forecast, by Product Type
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Mexico
8.4.6.3.1 Market size and forecast, by Technology
8.4.6.3.2 Market size and forecast, by Product Type
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by End User
8.5 Europe
8.5.1 Key trends and opportunities
8.5.2 Europe Market size and forecast, by Technology
8.5.3 Europe Market size and forecast, by Product Type
8.5.4 Europe Market size and forecast, by Application
8.5.5 Europe Market size and forecast, by End User
8.5.6 Europe Market size and forecast, by country
8.5.6.1 Germany
8.5.6.1.1 Market size and forecast, by Technology
8.5.6.1.2 Market size and forecast, by Product Type
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 France
8.5.6.2.1 Market size and forecast, by Technology
8.5.6.2.2 Market size and forecast, by Product Type
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 United Kingdom
8.5.6.3.1 Market size and forecast, by Technology
8.5.6.3.2 Market size and forecast, by Product Type
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Italy
8.5.6.4.1 Market size and forecast, by Technology
8.5.6.4.2 Market size and forecast, by Product Type
8.5.6.4.3 Market size and forecast, by Application
8.5.6.4.4 Market size and forecast, by End User
8.5.6.5 Spain
8.5.6.5.1 Market size and forecast, by Technology
8.5.6.5.2 Market size and forecast, by Product Type
8.5.6.5.3 Market size and forecast, by Application
8.5.6.5.4 Market size and forecast, by End User
8.5.6.6 Rest of Europe
8.5.6.6.1 Market size and forecast, by Technology
8.5.6.6.2 Market size and forecast, by Product Type
8.5.6.6.3 Market size and forecast, by Application
8.5.6.6.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Avance Biosciences
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Bio-Rad Laboratories, Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Fluidigm Corporation
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 jn medsys
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Merck KGAA
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Precigenome LLC
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 QIAGEN N.V
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 STILLA TECHNOLOGIES
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 sysmex corporation
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermo Fisher Scientific, Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 2. DIGITAL PCR MARKET REVENUE, FOR DROPLET DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 3. DIGITAL PCR MARKET DROPLET DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. DIGITAL PCR MARKET REVENUE, FOR CHIP BASED DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 5. DIGITAL PCR MARKET CHIP BASED DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. DIGITAL PCR MARKET REVENUE, FOR BEAMING DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 7. DIGITAL PCR MARKET BEAMING DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 9. DIGITAL PCR MARKET REVENUE, FOR DIGITAL PCR SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 10. DIGITAL PCR MARKET DIGITAL PCR SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. DIGITAL PCR MARKET REVENUE, FOR CONSUMABLES AND REAGENTS, BY REGION , 2020-2030,($MILLION)
TABLE 12. DIGITAL PCR MARKET CONSUMABLES AND REAGENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. DIGITAL PCR MARKET REVENUE, FOR SOFTWARE AND SERVICES, BY REGION , 2020-2030,($MILLION)
TABLE 14. DIGITAL PCR MARKET SOFTWARE AND SERVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. GLOBAL DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 16. DIGITAL PCR MARKET REVENUE, FOR RESEARCH, BY REGION , 2020-2030,($MILLION)
TABLE 17. DIGITAL PCR MARKET RESEARCH BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. DIGITAL PCR MARKET REVENUE, FOR CLINICAL DIAGNOSTICS, BY REGION , 2020-2030,($MILLION)
TABLE 19. DIGITAL PCR MARKET CLINICAL DIAGNOSTICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. DIGITAL PCR MARKET REVENUE, FOR FORENSIC AND OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 21. DIGITAL PCR MARKET FORENSIC AND OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. GLOBAL DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 23. DIGITAL PCR MARKET REVENUE, FOR PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRIES, BY REGION , 2020-2030,($MILLION)
TABLE 24. DIGITAL PCR MARKET PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. DIGITAL PCR MARKET REVENUE, FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION , 2020-2030,($MILLION)
TABLE 26. DIGITAL PCR MARKET CLINICAL DIAGNOSTIC LABORATORIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. DIGITAL PCR MARKET REVENUE, FOR UNIVERSITIES AND OTHER ORGANIZATIONS, BY REGION , 2020-2030,($MILLION)
TABLE 28. DIGITAL PCR MARKET UNIVERSITIES AND OTHER ORGANIZATIONS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. DIGITAL PCR MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 30. ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 31. ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 32. ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 33. ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 34. ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 35. JAPAN DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 36. JAPAN DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 37. JAPAN DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 38. JAPAN DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 39. CHINA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 40. CHINA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 41. CHINA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 42. CHINA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. AUSTRALIA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 44. AUSTRALIA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 45. AUSTRALIA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 46. AUSTRALIA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. INDIA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 48. INDIA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 49. INDIA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 50. INDIA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. SOUTH KOREA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 52. SOUTH KOREA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 53. SOUTH KOREA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 54. SOUTH KOREA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 56. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 57. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 58. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 59. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 60. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 61. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 62. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 63. LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 64. LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 65. LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 66. LAMEA DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 67. LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 68. BRAZIL DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 69. BRAZIL DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 70. BRAZIL DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 71. BRAZIL DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 72. SAUDI ARABIA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 73. SAUDI ARABIA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 74. SAUDI ARABIA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 75. SAUDI ARABIA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 76. SOUTH AFRICA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 77. SOUTH AFRICA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 78. SOUTH AFRICA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 79. SOUTH AFRICA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. REST OF LAMEA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 81. REST OF LAMEA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 82. REST OF LAMEA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 83. REST OF LAMEA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 84. NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 85. NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 86. NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 87. NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 88. NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 89. U.S. DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 90. U.S. DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 91. U.S. DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 92. U.S. DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 93. CANADA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 94. CANADA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 95. CANADA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 96. CANADA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 97. MEXICO DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 98. MEXICO DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 99. MEXICO DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 100. MEXICO DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 101. EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 102. EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 103. EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 104. EUROPE DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 105. EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 106. GERMANY DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 107. GERMANY DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 108. GERMANY DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 109. GERMANY DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 110. FRANCE DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 111. FRANCE DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 112. FRANCE DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 113. FRANCE DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 114. UNITED KINGDOM DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 115. UNITED KINGDOM DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 116. UNITED KINGDOM DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 117. UNITED KINGDOM DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 118. ITALY DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 119. ITALY DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 120. ITALY DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 121. ITALY DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 122. SPAIN DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 123. SPAIN DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 124. SPAIN DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 125. SPAIN DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 126. REST OF EUROPE DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 127. REST OF EUROPE DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 128. REST OF EUROPE DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 129. REST OF EUROPE DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 130.AVANCE BIOSCIENCES: COMPANY SNAPSHOT
TABLE 131.AVANCE BIOSCIENCES: OPERATING SEGMENTS
TABLE 132.AVANCE BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 133.AVANCE BIOSCIENCES: NET SALES,
TABLE 134.AVANCE BIOSCIENCES: KEY STRATERGIES
TABLE 135.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 136.BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 137.BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 138.BIO-RAD LABORATORIES, INC.: NET SALES,
TABLE 139.BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
TABLE 140.FLUIDIGM CORPORATION: COMPANY SNAPSHOT
TABLE 141.FLUIDIGM CORPORATION: OPERATING SEGMENTS
TABLE 142.FLUIDIGM CORPORATION: PRODUCT PORTFOLIO
TABLE 143.FLUIDIGM CORPORATION: NET SALES,
TABLE 144.FLUIDIGM CORPORATION: KEY STRATERGIES
TABLE 145.JN MEDSYS: COMPANY SNAPSHOT
TABLE 146.JN MEDSYS: OPERATING SEGMENTS
TABLE 147.JN MEDSYS: PRODUCT PORTFOLIO
TABLE 148.JN MEDSYS: NET SALES,
TABLE 149.JN MEDSYS: KEY STRATERGIES
TABLE 150.MERCK KGAA: COMPANY SNAPSHOT
TABLE 151.MERCK KGAA: OPERATING SEGMENTS
TABLE 152.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 153.MERCK KGAA: NET SALES,
TABLE 154.MERCK KGAA: KEY STRATERGIES
TABLE 155.PRECIGENOME LLC: COMPANY SNAPSHOT
TABLE 156.PRECIGENOME LLC: OPERATING SEGMENTS
TABLE 157.PRECIGENOME LLC: PRODUCT PORTFOLIO
TABLE 158.PRECIGENOME LLC: NET SALES,
TABLE 159.PRECIGENOME LLC: KEY STRATERGIES
TABLE 160.QIAGEN N.V: COMPANY SNAPSHOT
TABLE 161.QIAGEN N.V: OPERATING SEGMENTS
TABLE 162.QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 163.QIAGEN N.V: NET SALES,
TABLE 164.QIAGEN N.V: KEY STRATERGIES
TABLE 165.STILLA TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 166.STILLA TECHNOLOGIES: OPERATING SEGMENTS
TABLE 167.STILLA TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 168.STILLA TECHNOLOGIES: NET SALES,
TABLE 169.STILLA TECHNOLOGIES: KEY STRATERGIES
TABLE 170.SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 171.SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 172.SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 173.SYSMEX CORPORATION: NET SALES,
TABLE 174.SYSMEX CORPORATION: KEY STRATERGIES
TABLE 175.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 176.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 177.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 178.THERMO FISHER SCIENTIFIC, INC.: NET SALES,
TABLE 179.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.DIGITAL PCR MARKET SEGMENTATION
FIGURE 2.DIGITAL PCR MARKET,2020-2030
FIGURE 3.DIGITAL PCR MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.DIGITAL PCR MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.DIGITAL PCR MARKET,BY TECHNOLOGY,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DROPLET DIGITAL PCR DIGITAL PCR MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CHIP BASED DIGITAL PCR DIGITAL PCR MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BEAMING DIGITAL PCR DIGITAL PCR MARKET,2020-2030(%)
FIGURE 15.DIGITAL PCR MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL PCR SYSTEMS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES AND REAGENTS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SOFTWARE AND SERVICES DIGITAL PCR MARKET,2020-2030(%)
FIGURE 19.DIGITAL PCR MARKET,BY APPLICATION,2020(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF RESEARCH DIGITAL PCR MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF CLINICAL DIAGNOSTICS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF FORENSIC AND OTHERS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 23.DIGITAL PCR MARKET,BY END USER,2020(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRIES DIGITAL PCR MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CLINICAL DIAGNOSTIC LABORATORIES DIGITAL PCR MARKET,2020-2030(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF UNIVERSITIES AND OTHER ORGANIZATIONS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 27.DIGITAL PCR MARKET BY REGION,2020
FIGURE 28.JAPAN DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 29.CHINA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 30.AUSTRALIA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 31.INDIA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH KOREA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 33.TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 35.BRAZIL DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 36.SAUDI ARABIA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 37.SOUTH AFRICA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 38.REST OF LAMEA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 39.U.S. DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 40.CANADA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 41.MEXICO DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 42.GERMANY DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 43.FRANCE DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 44.UNITED KINGDOM DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 45.ITALY DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 46.SPAIN DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 47.REST OF EUROPE DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52.COMPETITIVE DASHBOARD
FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 54.AVANCE BIOSCIENCES.: NET SALES ,($MILLION)
FIGURE 55.BIO-RAD LABORATORIES, INC..: NET SALES ,($MILLION)
FIGURE 56.FLUIDIGM CORPORATION.: NET SALES ,($MILLION)
FIGURE 57.JN MEDSYS.: NET SALES ,($MILLION)
FIGURE 58.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 59.PRECIGENOME LLC.: NET SALES ,($MILLION)
FIGURE 60.QIAGEN N.V.: NET SALES ,($MILLION)
FIGURE 61.STILLA TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 62.SYSMEX CORPORATION.: NET SALES ,($MILLION)
FIGURE 63.THERMO FISHER SCIENTIFIC, INC..: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global digital PCR market was valued at $508.8 million in 2020, and is projected to reach $1,305.3 million by 2030, registering a CAGR of 8.6% from 2021 to 2030. Digital polymerase chain reaction (dPCR) is defined as an approach for the detection & quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in research (basic research and applied research), clinical diagnostics, forensics, and other similar areas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. For instance, according to World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 across the globe. Droplet digital PCR (ddPCR) is one of the analysis tests to detect the presence of mycobacterium tuberculosis. In addition, advancements in the technology in healthcare sector are anticipated to boost the market growth during the forecast period.
However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, surge in funding for R&D activities in medical devices sector is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR.
By product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players that operate in the global digital polymerase chain reaction market include Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, JN Medsys, Merck KGaA, PreciGenome LLC, Qiagen N.V, Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific, Inc.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an in-depth analysis of the global digital PCR market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global digital PCR market growth.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（diagnostic）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（diagnostic）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?